AP-HM - Hôpital Nord
- Address
- Chemin des Bourrely, 13915 Marseille, France
Neoplasms
The Thoracic Oncology unit at AP-HM - Hôpital Nord conducts research on advanced or metastatic Non‑Small Cell Lung Cancer, aiming to improve patient survival through novel immunotherapy strategies.
- Immune checkpoint inhibitor resistance
- Combination therapy with N‑803 and Tislelizumab
- Comparison of docetaxel‑based regimens
This work positions the Marseille site as a hub for cutting‑edge lung cancer trials.
Nutritional and Metabolic Diseases
A parallel study evaluates the impact of testosterone gel on muscle strength and physical performance in critically ill patients during the acute phase of illness.
- Muscle wasting prevention in ICU
- Physical function recovery at three months
- Hormone therapy versus placebo
The trial reflects the site’s commitment to metabolic support for patients with severe disease.
Respiratory Tract Diseases
Investigations target individuals who require invasive mechanical ventilation for more than 48 hours, seeking to reduce complications and enhance lung recovery.
- Ventilator‑associated complications
- Strategies to improve respiratory function
- Outcomes of prolonged ventilation support
These efforts underscore the department’s focus on critical respiratory care at the Hôpital Nord.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
- 1Immunitybio Inc.1active
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in AP-HM - Hôpital Nord
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Testosterone Gel on Physical Performance in Patients Requiring Prolonged Invasive Mechanical Ventilation: A Randomized, Double-Blind, Placebo-Controlled Trial | University Hospital Of Clermont-Ferrand | Phase II | Recruiting | Jul 2023 | — |
IMP list
lock Showing 1 of 4 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Docetaxel | 1 | Unknown | — | — |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.